Check out our most popular compounded medications! Get Started
Estriol 0.3% Topical Gel is a semisolid formulation used for the treatment of conditions such as vulvovaginal atrophy, lichen sclerosus, lichen planus, genitourinary syndrome of menopause, and postmenopausal vaginal dryness. Dispensed through a pump mechanism, it allows for easy and precise application directly to the affected area, ensuring targeted treatment or absorption of the active ingredients.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Estriol 0.3% Topical Gel is a specially compounded medication designed to treat a range of skin conditions. This includes Atopic Dermatitis, Lichen Sclerosus, Vulvovaginal Atrophy, Lichen Planus, and Genitourinary Syndrome of Menopause. The active ingredient, Estriol, is a form of estrogen that works by reducing inflammation and restoring the skin's natural barrier. This medication is applied directly to the affected area, providing targeted treatment for up to three times a day.
This semisolid formulation is dispensed through a pump mechanism, facilitating easy and precise application on the skin. The gel-like consistency allows for optimal absorption of the active ingredients. It also improves skin hydration and elasticity, contributing to overall skin health.
For patients with Atopic Dermatitis, Lichen Sclerosus, Vulvovaginal Atrophy, Lichen Planus, or Genitourinary Syndrome of Menopause, Estriol 0.3% Topical Gel can provide significant relief. It reduces inflammation and itching, while also improving skin hydration and elasticity. This can lead to a noticeable improvement in the condition of the skin and a reduction in discomfort.
It is crucial to follow the instructions of your healthcare provider when using Estriol 0.3% Topical Gel. If you have any questions or concerns about this medication, please do not hesitate to contact us at Bayview Pharmacy. We are here to assist you with your healthcare needs.
Estriol 0.3% Topical Gel is a semisolid formulation designed for easy and precise application on the skin. It is dispensed through a pump mechanism, ensuring targeted treatment or absorption of the active ingredient, Estriol, in a gel-like consistency. This formulation is indicated for the treatment of various skin and genitourinary conditions such as Atopic Dermatitis, Lichen Sclerosus, Vulvovaginal Atrophy, Lichen Planus, and Genitourinary Syndrome of Menopause.
Estriol, a weak estrogen, has been shown to reduce inflammation and itching associated with Atopic Dermatitis. In the treatment of Vulvovaginal Atrophy, a condition characterized by thinning of the vaginal walls and decreased lubrication, Estriol has been used with success. It has also been used to treat Lichen Planus, a condition characterized by itchy, scaly patches on the skin. Lastly, Estriol has been used to alleviate the symptoms of Genitourinary Syndrome of Menopause, a condition characterized by vaginal dryness, burning, and itching.
Estriol 0.3% Topical Gel should be applied to the affected area twice daily. However, it is important to note that Estriol should not be used by pregnant or breastfeeding women, as it may cause harm to the fetus or infant. Additionally, Estriol should not be used by women with a history of breast cancer or other estrogen-sensitive conditions. If you have any questions about using Estriol 0.3% Topical Gel, please consult with your healthcare provider.
Estriol 0.3% Topical Gel is a specially formulated medication designed to treat a range of skin conditions. The active ingredient, Estriol, is a type of estrogen hormone that plays a crucial role in maintaining the health of the skin and the body's immune system.
The gel works by reducing inflammation and itching, and by restoring the skin's natural barrier. It is also beneficial in alleviating the symptoms associated with Genitourinary Syndrome of Menopause, such as vaginal dryness and discomfort during intercourse. The gel's consistency allows for easy and precise application, ensuring that the active ingredients are targeted directly to the affected area.
Typically, Estriol 0.3% Topical Gel is applied once or twice daily, or as directed by a healthcare provider. It is essential to follow the instructions provided by your healthcare provider to ensure the medication's effectiveness. Avoid contact with the eyes, mouth, and other mucous membranes when applying the gel. If you experience any side effects, such as skin irritation or burning, it is important to contact your healthcare provider immediately.
Estriol 0.3% Topical Gel is a appropriate treatment option for various skin conditions. It is designed to reduce inflammation and itching, restore the skin's natural barrier, and alleviate symptoms of Genitourinary Syndrome of Menopause. If you have any questions or concerns about using Estriol 0.3% Topical Gel, it is recommended to consult with your healthcare provider for further information and guidance.
Estriol 0.3% Topical Gel is a compounded formulation that has been effectively used in the treatment of various conditions. These include Vulvovaginal Atrophy, Lichen Sclerosus, Lichen Planus, Genitourinary Syndrome of Menopause, and Postmenopausal Vaginal Dryness. It has also been beneficial in addressing symptoms such as vaginal itching, burning, and irritation. The gel has been found to potentially reduce the risk of recurrent urinary tract infections and may also be used as a preventive measure against urinary incontinence.
Furthermore, Estriol 0.3% Topical Gel has been used to lower the risk of developing vaginal infections, including bacterial vaginosis and yeast infections. It is generally well tolerated by most patients and can be used in conjunction with other treatments, such as hormone replacement therapy. However, it is important to note that Estriol 0.3% Topical Gel may cause skin irritation in some individuals, and should therefore be used with caution.
Patients are encouraged to consult with their healthcare provider or pharmacist if they have any questions or concerns about using Estriol 0.3% Topical Gel. It is crucial to use this medication as directed by a healthcare professional to ensure its effectiveness and to minimize potential side effects.
Estriol 0.3% Topical Gel is a semisolid formulation that is dispensed through a pump mechanism. It is designed for easy and precise application on the skin for targeted treatment or absorption of active ingredients.
The pump mechanism allows for a controlled amount of the gel to be dispensed each time, ensuring that you apply the correct dosage. It also minimizes waste and mess associated with traditional tubes or jars.
The gel has a semisolid, gel-like consistency that is designed to be easily spreadable on the skin for optimal absorption.
You should apply the gel to the targeted area as directed by your healthcare provider. The pump mechanism allows for precise application.
Estriol 0.3% Topical Gel is designed for targeted treatment, so it should be applied to the specific area as directed by your healthcare provider.
The active ingredient in this gel is Estriol, a form of estrogen, at a concentration of 0.3%.
A gel formulation allows for targeted treatment and optimal absorption of the active ingredient into the skin. It is also easy to apply and less messy than creams or lotions.
If you have sensitive skin, you should consult with your healthcare provider before using Estriol 0.3% Topical Gel. They can provide guidance based on your specific skin type and condition.
The frequency of use will depend on your specific treatment plan as determined by your healthcare provider. Always follow their instructions for use.
If you experience any side effects from using Estriol 0.3% Topical Gel, you should immediately stop using it and contact your healthcare provider for guidance.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Apply topically to affected area(s)
